XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENT OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Redeemable Convertible Preferred Stock
Common Stock
Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance, redeemable convertible preferred stock (in shares) at Jun. 30, 2020     122,115,971            
Beginning balance, redeemable convertible preferred stock at Jun. 30, 2020     $ 804,170            
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)     21,836,687            
Issuance of redeemable convertible preferred stock, net of issuance costs     $ 434,542            
Conversion of convertible debt (in shares)     4,444,321            
Conversion of convertible debt     $ 88,559            
Conversion of redeemable convertible preferred stock (in shares)     (148,396,979)            
Issuance of common stock, employee share purchase plan $ 1,327,271   $ (1,327,271)            
Ending balance, redeemable convertible preferred stock (in shares) at Jun. 30, 2021     0            
Ending balance, redeemable convertible preferred stock at Jun. 30, 2021     $ 0            
Beginning balance, common stock (in shares) at Jun. 30, 2020         47,684,427        
Beginning balance at Jun. 30, 2020 (367,096)       $ 0 $ 80,373 $ (447,167)   $ (302)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of convertible debt (42,124)         (42,124)      
Conversion of redeemable convertible preferred stock (in shares)         148,396,979        
Issuance of common stock, employee share purchase plan 1,327,260       $ 2 1,327,269 (11)    
Issuance of common stock (in shares)         28,290,000        
Issuance of common stock 1,305,177       $ 1 1,305,176      
Issuance of common stock upon exercise of stock option (in shares)         12,418,931        
Vesting of restricted stock units 46,462         46,462      
Issuance of common stock upon exercise of warrants (in shares)         20,651,583        
Vesting of warrants for common stock 271,156         271,156      
Issuance of common stock in acquisitions (in shares)         9,167,515        
Issuance of common stock in acquisitions 331,498         331,498      
Vesting of restricted stock units (in shares)         2,878,060        
Repurchases of common stock (in shares)         (129,391)        
Tax withholding on stock-based compensation (800)         (800)      
Foreign currency translation adjustments 306,506         306,506      
Unrealized loss on securities available for sale (158,280)         (158,280)      
Deconsolidation of variable interest entity (300)           (300)    
Foreign currency translation adjustments 7,046               7,046
Unrealized loss on securities available for sale 29               29
Net loss (441,027)           (441,027)    
Ending balance, common stock (in shares) at Jun. 30, 2021         269,358,104        
Ending balance at Jun. 30, 2021 2,575,527 $ (9,980)     $ 3 3,467,236 (898,485) $ (9,980) 6,773
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of common stock, employee share purchase plan 0                
Ending balance, redeemable convertible preferred stock (in shares) at Jun. 30, 2022     0            
Ending balance, redeemable convertible preferred stock at Jun. 30, 2022     $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock option (in shares)         13,565,397        
Issuance of common stock, employee share purchase plan (in shares)         149,137        
Issuance of common stock, employee share purchase plan 3,613         3,613      
Vesting of restricted stock units $ 69,876         69,876      
Issuance of common stock upon exercise of warrants (in shares) 0                
Issuance of common stock in acquisitions (in shares)         488,097        
Issuance of common stock in acquisitions $ 42,109         42,109      
Vesting of restricted stock units (in shares)         3,815,156        
Vesting of warrants for common stock 388,208         388,208      
Repurchases of common stock (in shares)         (10,518)        
Tax withholding on stock-based compensation (86)         (86)      
Foreign currency translation adjustments 445,525         445,525      
Unrealized loss on securities available for sale (185,178)         (185,178)      
Foreign currency translation adjustments (5,900)               (5,900)
Unrealized loss on securities available for sale (8,022)               (8,022)
Net loss (707,417)           (707,417)    
Ending balance, common stock (in shares) at Jun. 30, 2022         287,365,373        
Ending balance at Jun. 30, 2022 2,618,255       $ 3 4,231,303 (1,605,902)   (7,149)
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of common stock, employee share purchase plan $ 0                
Ending balance, redeemable convertible preferred stock (in shares) at Jun. 30, 2023     0            
Ending balance, redeemable convertible preferred stock at Jun. 30, 2023     $ 0            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of stock option (in shares) 971,863       947,792        
Issuance of common stock, employee share purchase plan (in shares)         954,475        
Issuance of common stock, employee share purchase plan $ 11,482         11,482      
Forfeiture of common stock related to acquisitions (in shares)       (258,905)          
Vesting of restricted stock units $ 4,593         4,593      
Issuance of common stock upon exercise of warrants (in shares) 0                
Issuance of common stock in acquisitions $ 13,674         13,674      
Vesting of restricted stock units (in shares)         7,849,919        
Vesting of warrants for common stock 421,934         421,934      
Repurchases of common stock (in shares)         (12,437)        
Tax withholding on stock-based compensation (109)         (109)      
Foreign currency translation adjustments 531,817         531,817      
Unrealized loss on securities available for sale (73,844)         (73,844)      
Foreign currency translation adjustments (8,143)               (8,143)
Unrealized loss on securities available for sale (882)               (882)
Unrealized gain on cash flow hedges 751               751
Net loss (985,345)           (985,345)    
Ending balance, common stock (in shares) at Jun. 30, 2023         296,846,217        
Ending balance at Jun. 30, 2023 $ 2,534,183       $ 3 $ 5,140,850 $ (2,591,247)   $ (15,423)